FBP1 Is a Tumor Suppressor Linking Hepatic Metabolism to Tumorigenesis

Article navigation

Research Watch| July 01 2020

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2020) 10 (7): OF13.

Abstract

Loss of the gluconeogenic enzyme FBP1 promoted hepatocellular carcinoma development in mice.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.